Tumor-treating fields plus chemotherapy versus chemotherapy alone for glioblastoma at first recurrence: a post hoc analysis of the EF-14 trial

The study was funded by NovoCure Ltd. S Kesari is a consultant with Novocure and has received research grants from the company. Z Ram is a consultant and shareholder with Novocure and has received research grants from the company. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.